Katia Martino
Pharmaceutical Science
NMS Group
Italy
Biography
Katia Martino is the board of director of NMS Group which is the leading pharmaceutical company of Italy. Nerviano Medical Sciences is focused on the discovery and early development of oncology drugs. Our business model is to partner our drugs at late preclinical or early clinical stage for full development and commercialization. Our mission is to pursue innovative therapeutic approaches in Oncology, discovering and developing molecules with novel mechanisms of action, for the advancement of personalized care of cancer patients. An experienced and lean management team leads a highly skilled staff of professionals with international experience and a broad range of expertise in R&D, combining the flexibility of a biotech with the quality standards of a big pharma.
Research Interest
Pharmaceutical sciences
